Table 3.
Severity markers of therapeutic measures in both groups
| Case group (underlying diseases) | Previously healthy group | P value | |
|---|---|---|---|
| Oxygen therapy | 184/225 (81·8%) | 334/458 (72·9%) | <0·05 |
| Median duration of oxygen therapy (IQR Q1-Q3) (days) | 3·0 (1·0–5·0) | 2·0 (0·0–3·0) | <0·001 |
| High-flow oxygen therapy | 32/225 (14·2%) | 33/460 (7·2%) | <0·01 |
| Median length of high-flow oxygen therapy (IQR Q1-Q3) (days) | 3·5 (2·0–5·75) | 2·0 (1·75–3·0) | <0·05 |
| Non-invasive ventilation | 24/225 (10·7%) | 36/460 (7·8%) | n.s. |
| Median length of non-invasive ventilation (IQR Q1-Q3) (days) | 4·0 (2·0–7·5) | 2·0 (1·0–4·0) | 0·057 |
| Mechanical ventilation | 14/225 (6·2%) | 8/460 (1·7%) | <0·01 |
| Median length of mechanical ventilation (IQR Q1-Q3) (days) | 7·0 (4·5–13·2) | 6·0 (5·7–6·0) | n.s. |
| Venous line | 114/225 (50·7%) | 160/452 (35·4%) | <0·001 |
| Nasogastric tube feeding | 41/212 (19·3%) | 42/419 (10·0%) | <0·01 |
| Antibiotic therapy | 111/225 (49·3%) | 136/452 (30·1%) | <0·001 |
| Length of stay (mean, days ± SD) | 8·03 (1·3) | 5·35 (0·3) | <0·01 |
| Admitted to PICU since first day of hospitalization | 13/225 (5·8%) | 22/460 (4·8%) | n.s. |
| Admitted to PICU during hospitalization | 42/225 (18·6%) | 52/454 (11·5%) | <0·05 |
| Median length of stay in PICU (IQR Q1-Q3) (days) | 5·0 (3·0–10·0) | 4·0 (2·0–5·0) | <0·05 |
PICU, pediatric intensive care unit; SD, standard deviation; n.s., non-significant; IQR, interquartile range.